CTTN and glioblastoma: Cortactin is overexpressed in many cancers [35,36] at high risk of invasiveness and metastasis, including hepatocellular carcinoma [37], colorectal cancer, glioblastoma, HNSCC, oral squamous cell carcinoma, lung squamous cell carcinoma, gliosarcoma, breast cancer, and melanoma [35].